A Qualitative Study to Assess the Content Validity of the 24‐Hour Migraine Quality of Life Questionnaire in Patients with Migraine von Speck, Rebecca M., Collins, Ethan M., Lombard, Louise, Ayer, David W.

Volltext

Psychometric validation and meaningful within‐patient change of the Migraine‐Specific Quality of Life questionnaire version 2.1 electronic patient‐reported outcome in patients with... von Speck, Rebecca M., Yu, Ren, Ford, Janet H., Ayer, David W., Bhandari, Rohit, Wyrwich, Kathleen W.

Volltext

Two randomized migraine studies of galcanezumab: Effects on patient functioning and disability von Ford, Janet H, Ayer, David W, Zhang, Qi, Carter, Jeffrey N, Leroux, Elizabeth, Skljarevski, Vladimir, Aurora, Sheena K, Tockhorn-Heidenreich, Antje, Lipton, Richard B

Volltext

Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study von Ford, Janet H., Stauffer, Virginia L., McAllister, Peter, Akkala, Sreelatha, Sexson, Matthew, Ayer, David W., Wang, Shufang

Volltext

Measures of Functioning in Patients With Episodic Migraine: Findings From a Double‐Blind, Randomized, Placebo‐Controlled Phase 2b Trial With Galcanezumab von Ayer, David W., Skljarevski, Vladimir, Ford, Janet H., Nyhuis, Allen W., Lipton, Richard B., Aurora, Sheena K.

Volltext

Psychometric Validation of the Role Function Restrictive Domain of the Migraine Specific Quality‐of‐Life Questionnaire Version 2.1 Electronic Patient‐Reported Outcome in Patients W... von Speck, Rebecca M., Shalhoub, Huda, Wyrwich, Kathleen W., Yu, Ren, Ayer, David W., Ford, Janet, Bush, Elizabeth N., Lipton, Richard B.

Volltext

Correction to: Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study von Ford, Janet H., Stauffer, Virginia L., McAllister, Peter, Akkala, Sreelatha, Sexson, Matthew, Ayer, David W., Wang, Shufang

Volltext

Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine von Ford, Janet H., Kurth, Tobias, Starling, Amaal J., Ayer, David W., Wietecha, Linda A., Port, Martha D., Rettiganti, Mallikarjuna, Ruff, Dustin D.

Volltext

Validation of the NetSCID: an automated web-based adaptive version of the SCID von Brodey, Benjamin B, First, Michael, Linthicum, Jared, Haman, Kirsten, Sasiela, Jordan W, Ayer, David

Volltext

Validation and meaningful within-patient change in work productivity and activity impairment questionnaire (WPAI) for episodic or chronic migraine von Ford, Janet H., Ye, Wenyu, Ayer, David W., Mi, Xiaojuan, Bhandari, Swati, Buse, Dawn C., Lipton, Richard B.

Volltext

Practice Elements Used With Depressed Clients by Community Mental Health Therapists von Lewis, Cara C, Ayer, David W, Marti, C. Nathan

Volltext

Content validity of the Migraine-Specific Quality of Life Questionnaire version 2.1 electronic patient-reported outcome von Speck, Rebecca M., Shalhoub, Huda, Ayer, David W., Ford, Janet H., Wyrwich, Kathleen W., Bush, Elizabeth N.

Volltext

The InterSePT suicide scale for prediction of imminent suicidal behaviors von Ayer, David W, Jayathilake, Karu, Meltzer, Herbert Y

Volltext

Long-term treatment with lasmiditan in patients with migraine: Results from the open-label extension of the CENTURION randomized trial von Ashina, Messoud, Roos, Caroline, Li, Lily Qian, Komori, Mika, Ayer, David, Ruff, Dustin, Krege, John Henry

Volltext

Maintenance Treatment With Varenicline for Smoking Cessation in Patients With Schizophrenia and Bipolar Disorder: A Randomized Clinical Trial von Evins, A. Eden, Cather, Corinne, Pratt, Sarah A, Pachas, Gladys N, Hoeppner, Susanne S, Goff, Donald C, Achtyes, Eric D, Ayer, David, Schoenfeld, David A

Volltext

Changes in patient functioning and disability: results from a phase 3, double-blind, randomized, placebo-controlled clinical trial evaluating galcanezumab for chronic migraine prev... von Ford, Janet, Tassorelli, Cristina, Leroux, Elizabeth, Wang, Shufang, Ayer, David, Nichols, Russell, Detke, Holland

Volltext

Patient Functioning and Disability among Patients with Migraine: Evaluation of Galcanezumab in a Long-Term, Open-Label Study (4002) von McAllister, Peter, Ford, Janet H., Stauffer, Virginia L., Sexson, Matthew, Ayer, David, Wang, Shufang

Volltext

Measures of functioning using MSQ v2.1 in patients with a history of episodic migraine and treated with galcanezumab or placebo injections in a Phase 2 clinical trial (P2.179) von Ford, Janet, Ayer, David, Nyhuis, Allen, Aurora, Sheena, Carter, Jeff

Volltext

Functional restoration with reyvow (FREE): A US-based cross-sectional survey in patients taking lasmiditan von Lombard, Louise, Schwedt, Todd, Doty, Erin, Vincent, Maurice, Mills, Kayla, Ayer, David, Mackie, Demauri, Decongelio, Marc, Hauck, Paula, Dougherty, Carrie

Volltext

Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study (Sep, 10.1007/s11136-020-02632-0, 2020) von Ford, Janet H., Stauffer, Virginia L., McAllister, Peter, Akkala, Sreelatha, Sexson, Matthew, Ayer, David W., Wang, Shufang

Volltext